Results 151 to 160 of about 69,057 (285)

Chronic silencing of subsets of cortical layer 5 pyramidal neurons has a long‐term influence on the laminar distribution of parvalbumin interneurons and the perineuronal nets

Journal of Anatomy, Volume 246, Issue 4, Page 479-504, April 2025.
Chronic silencing of subsets of layer 5 projection neurons has distinct effects on the laminar distribution of PV interneurons and the perineuronal nets in the adult primary motor and somatosensory cortex. Abstract Neural networks are established throughout cortical development, which require the right ratios of glutamatergic and GABAergic neurons ...
Florina P. Szabó, Veronika Sigutova, Anna M. Schneider, Anna Hoerder‐Suabedissen, Zoltán Molnár   +4 more
wiley   +1 more source

Incidence and Characteristics of Hospital‐Acquired Pressure Injuries in Acute Palliative Care Patients: A Four‐Year Analysis

Journal of Clinical Nursing, EarlyView.
ABSTRACT Aim To describe the cumulative incidence and characteristics of hospital‐acquired pressure injury in acute palliative patients. Design Secondary data analysis of hospital‐acquired pressure injuries during 2019–2022. Methods The setting was a palliative care unit at a tertiary hospital in Queensland, Australia, including adult (≥ 18 years ...
Saroeun Ven, Michael Steele, Adam Burston, Paul Fulbrook, Josephine Lovegrove, Sandra Miles, Susan Prince   +6 more
wiley   +1 more source

Somatostatin receptor 2 is highly sensitive and specific for Epstein-Barr virus-associated nasopharyngeal carcinoma. [PDF]

Hum Pathol, 2021
Viswanathan K, Sadow PM.
europepmc   +1 more source

Nuclear medicine in endocrine tumours [PDF]

, 2011
C
Peremans, Kathelijne, Van De Wiele, Christophe   +1 more
core   +2 more sources

Characterisation of sleep apneas and respiratory circuitry in mice lacking CDKL5

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary CDKL5 deficiency disorder is a rare genetic disease caused by mutations in the CDKL5 gene. Central apneas during wakefulness have been reported in patients with CDKL5 deficiency disorder. Studies on CDKL5‐knockout mice, a CDKL5 deficiency disorder model, reported sleep apneas, but it is still unclear whether these events are central (central ...
Gabriele Matteoli, Sara Alvente, Stefano Bastianini, Chiara Berteotti, Elisabetta Ciani, Elenia Cinelli, Viviana Lo Martire, Giorgio Medici, Tommaso Mello, Elena Miglioranza, Alessandro Silvani, Donatella Mutolo, Giovanna Zoccoli   +12 more
wiley   +1 more source

Correlation of Somatostatin Receptor 2 Expression, 68Ga-DOTATATE PET Scan and Octreotide Treatment in Thymic Epithelial Tumors. [PDF]

Front Oncol, 2022
Roden AC, Rakshit S, Johnson GB, Jenkins SM, Mansfield AS.   +4 more
europepmc   +1 more source

Somatostatin 2 Receptors in the Spinal Cord Tonically Restrain Thermogenic, Cardiac and Other Sympathetic Outflows [PDF]

, 2019
Belinda R. Bowman, Phillip Bokiniec, Simon McMullan, Ann K. Goodchild, Peter G.R. Burke   +4 more
openalex   +1 more source

Supplementary Figure 8 from ¹⁷⁷Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer

, 2023
Shilpa Thakur, Brianna Daley, Corina Millo, Craig Cochran, Orit Jacobson, Huiyan Lu, Zhantong Wang, Dale O. Kiesewetter, Xiaohong Chen, Vasyl Vasko, Joanna Kłubo-Gwieździńska   +10 more
openalex   +1 more source

Surgical Treatment for Osteomalacia Induced by Causative Tumor in the Knee Joint Region: A Single‐Center Retrospective Clinical Study Over 10 Years

Orthopaedic Surgery, EarlyView.
The causative tumor for TIO in the knee joint region is hidden and has diverse locations, resulting in great challenges to endocrinologist and orthopedists. Due to the unique anatomical location and complex structure of the knee joint, orthopedic surgeons can adopt different surgical approaches to completely remove the causative tumor.
Shuzhong Liu, Xi Zhou, Jinyi Xing, Zhen Huo, Mingjing Zhang, Bo Yang, Yong Liu, Weibo Xia   +7 more
wiley   +1 more source

Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses.

J Clin Endocrinol Metab, 2023
Fischer A, Kloos S, Maccio U, Friemel J, Remde H, Fassnacht M, Pamporaki C, Eisenhofer G, Timmers HJLM, Robledo M, Fliedner SMJ, Wang K, Maurer J, Reul A, Zitzmann K, Bechmann N, Žygienė G, Richter S, Hantel C, Vetter D, Lehmann K, Mohr H, Pellegata NS, Ullrich M, Pietzsch J, Ziegler CG, Bornstein SR, Kroiss M, Reincke M, Pacak K, Grossman AB, Beuschlein F, Nölting S.   +32 more
europepmc   +1 more source